Implement Controlled Access to Data Entry Terminals in GMP Areas

Ensure Controlled Access to GMP Data Entry Terminals

Remember: Only authorized personnel should access GMP data terminals using secure login credentials.

Why This Matters in GMP

Unrestricted or shared access to data entry terminals increases the risk of data manipulation, unauthorized changes, and loss of traceability. In GMP environments, electronic records are as critical as physical ones. Terminals used for recording, reviewing, or transmitting GMP data must have role-based access to ensure accountability. Shared user credentials or generic logins violate data integrity expectations and hinder investigation of discrepancies. Without controlled access, there is no assurance that the data entered is attributable, legible, contemporaneous, original, and accurate (ALCOA principles). Data breaches or unauthorized s can compromise product quality, delay batch release, and trigger major compliance failures.

Also Read: Do Not Record Test Results Before Completing the Analysis

Regulatory and Compliance Implications

FDA 21 CFR Part 11 and EU GMP Annex 11 mandate secure, role-based access controls for electronic systems. These controls must support audit trails, password management, and user authentication. WHO GMP and Schedule M also emphasize the need for electronic data security and traceability. Noncompliance with access controls has led to significant regulatory actions, including FDA warning letters for inadequate user rights management. Regulatory auditors

often review user logs, password expiry settings, and system controls to assess integrity. Systems must allow only authorized users to enter or GMP data, with clear documentation of who did what, and when.

Also Read: Don’t Discard QC Samples Without Prior QA Clearance in GMP

Implementation Best Practices

Establish unique user IDs and password protocols for every operator accessing GMP terminals.
Configure role-based access limits according to job responsibilities (e.g., read-only, data entry, review).
Install timeout features and password expiration policies for inactive terminals.
Conduct regular audits of access logs and permissions to detect anomalies.
Document SOPs for access approval, revocation, and terminal usage.

Regulatory References

FDA 21 CFR Part 11 – Electronic Records; Electronic Signatures
EU GMP Annex 11 – Computerized Systems
WHO GMP – Computer System Validation Guidelines
Schedule M – Controls on Electronic Records